| NLBS Stock | | | USD 0.0001 0.00 0.00% |
CEO
Mr. Edgar Ward is Chief Executive Officer, President and Director of the Company. From April 1, 2010 to present, Edgar Ward has served as our Chief Executive Officer, President and Sole Director. From January 1, 2008, until June 30, 2010, Mr. Ward was the Chief Executive Officer at SkyRockit Records. since 2010.
| Age | 51 |
| Tenure | 14 years |
| Phone | 888 509 8901 |
| Web | https://www.nutralifebiosciences.com |
Nutralife Biosciences Management Efficiency
The company has return on total asset
(ROA) of
(0.2848) % which means that it has lost $0.2848 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(14.2602) %, meaning that it created substantial loss on money invested by shareholders. Nutralife Biosciences' management efficiency ratios could be used to measure how well Nutralife Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.
Nutralife Biosciences currently holds 10
K in liabilities. Nutralife Biosciences has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nutralife Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Nutralife Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nutralife Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nutralife to invest in growth at high rates of return. When we think about Nutralife Biosciences' use of debt, we should always consider it together with cash and equity.
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol products. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida. Nutralife Biosciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people. Nutralife Biosciences [NLBS] is a
Pink Sheet which is traded between brokers as part of OTC trading.
Management Performance
Nutralife Biosciences Leadership Team
Elected by the shareholders, the Nutralife Biosciences' board of directors comprises two types of representatives: Nutralife Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nutralife. The board's role is to monitor Nutralife Biosciences' management team and ensure that shareholders' interests are well served. Nutralife Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nutralife Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Nutralife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Nutralife Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Nutralife Pink Sheet Analysis
When running Nutralife Biosciences' price analysis, check to
measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to
predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.